sertraline has been researched along with Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tchernev, G | 1 |
| Amson, R; Appel, MH; BasÃlio, AB; Boia-Ferreira, M; Chaim, OM; Da Costa, CRV; Hamasaki, AE; Matsubara, FH; Senff-Ribeiro, A; Telerman, A; Veiga, SS | 1 |
| Arbiser, JL; Bhandarkar, SS; Carracedo, A; Carrillo, CO; Chen, LB; Govindarajan, B; Lefkove, B; Mechta-Grigoriou, F; Owens, MJ; Reddy, KK; Velasco, G | 1 |
3 other study(ies) available for sertraline and Melanoma
| Article | Year |
|---|---|
NITROSOGENESIS, ANTIDEPRESSANTS AND THE SERTRALIN INDUCED NEVUS ASSOCIATED CUTANEOUS MELANOMA: THE NDMA/ NNK (NDSRIS) CONTAMINATION AS MOST POTENT MELANOMA INDUCTORS: ALEA IACTA EST.
Topics: Animals; Antidepressive Agents; Carcinogens; Humans; Melanoma; Melanoma, Cutaneous Malignant; Nevus; Nevus, Pigmented; Nitrosamines; Prospective Studies; Rats; Sertraline; Skin Neoplasms | 2023 |
TCTP as a therapeutic target in melanoma treatment.
Topics: Animals; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dacarbazine; Female; Gene Expression; Gene Silencing; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; RNA, Messenger; RNA, Small Interfering; Sertraline; Skin Neoplasms; Transfection; Tumor Protein, Translationally-Controlled 1; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2017 |
The antidepressant sertraline downregulates Akt and has activity against melanoma cells.
Topics: Animals; Antidepressive Agents; Antineoplastic Agents; Cell Proliferation; Down-Regulation; Humans; Male; Melanoma; Mice; Mice, Nude; Oncogene Protein v-akt; Phosphorylation; Sertraline; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |